Literature DB >> 12556341

Evidence for the involvement of DNA-dependent protein kinase in the phenomena of low dose hyper-radiosensitivity and increased radioresistance.

B Marples1, N E Cann, C R Mitchell, P J Johnston, M C Joiner.   

Abstract

PURPOSE: To investigate the role of DNA-dependent protein kinase (DNA-PK) in the phenomena of low dose hyper-radiosensitivity (HRS) and increased radioresistance (IRR) using the genetically related M059 cell lines of disparate PRKDC status.
MATERIALS AND METHODS: Clonogenic survival was measured for the three cell lines following low doses of X-irradiation using a flowactivated cell sorting (FACS) plating technique. The presence of PRKDC, G22p1 and Xrcc5 proteins was determined by Western blotting and a kinase assay used to measure DNA-PK complex activity.
RESULTS: The survival responses for the three cell lines over the 0-0.3Gy dose range were comparable, but differences in radiosensitivity were evident at doses >0.4Gy. M059K and M059J/Fus1 cells (both PRKDC competent) exhibited marked HRS/IRR responses, albeit to different extents. M059J cells (PRKDC incompetent) were extremely radiosensitive exhibiting a linear survival curve with no evidence of IRR. The presence of IRR was coincident with the presence of PRKDC protein and functional DNA-PK activity.
CONCLUSIONS: HRS is a response that is independent of DNA-PK activity. In contrast, IRR showed a dependence on the presence of PRKDC protein and functional DNA-PK activity. These data support a role for DNA-PK activity in the IRR response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12556341     DOI: 10.1080/09553000210166606

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  10 in total

1.  Association of ATM activation and DNA repair with induced radioresistance after low-dose irradiation.

Authors:  L Enns; A Rasouli-Nia; M Hendzel; B Marples; M Weinfeld
Journal:  Radiat Prot Dosimetry       Date:  2015-04-22       Impact factor: 0.972

2.  Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study.

Authors:  Chaim B Colen; Navid Seraji-Bozorgzad; Brian Marples; Matthew P Galloway; Andrew E Sloan; Saroj P Mathupala
Journal:  Neurosurgery       Date:  2006-12       Impact factor: 4.654

3.  Low-dose fractionated radiation with induction chemotherapy for locally advanced head and neck cancer: 5 year results of a prospective phase II trial.

Authors:  John F Gleason; Mahesh Kudrimoti; Emily M Van Meter; Mohammed Mohiuddin; William F Regine; Joseph Valentino; Daniel Kenady; Susanne M Arnold
Journal:  J Radiat Oncol       Date:  2013-03-01

4.  VorinostatSAHA Promotes Hyper-Radiosensitivity in Wild Type p53 Human Glioblastoma Cells.

Authors:  Eric Diss; NarasimhaRao Nalabothula; Duc Nguyen; Elizabeth Chang; Young Kwok; France Carrier
Journal:  J Clin Oncol Res       Date:  2014-01-15

5.  Low-LET-induced radioprotective mechanisms within a stochastic two-stage cancer model.

Authors:  H Schöllnberger; R D Stewart; R E J Mitchel
Journal:  Dose Response       Date:  2006-05-22       Impact factor: 2.658

6.  A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.

Authors:  Bo Wang; Dongping Li; Corinne Sidler; Rocio Rodriguez-Juarez; Natasha Singh; Mieke Heyns; Yaroslav Ilnytskyy; Roderick T Bronson; Olga Kovalchuk
Journal:  Oncotarget       Date:  2015-04-30

7.  Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial.

Authors:  Susanne M Arnold; Mahesh Kudrimoti; Emily V Dressler; John F Gleason; Natalie L Silver; William F Regine; Joseph Valentino
Journal:  Adv Radiat Oncol       Date:  2016-07-14

8.  Datasets of in vitro clonogenic assays showing low dose hyper-radiosensitivity and induced radioresistance.

Authors:  Szabolcs Polgár; Paul N Schofield; Balázs G Madas
Journal:  Sci Data       Date:  2022-09-08       Impact factor: 8.501

9.  Cell division cycle 25 homolog c effects on low-dose hyper-radiosensitivity and induced radioresistance at elevated dosage in A549 cells.

Authors:  Yanxia Zhao; Yingshan Cui; Jun Han; Jinghua Ren; Gang Wu; Jing Cheng
Journal:  J Radiat Res       Date:  2012-06-06       Impact factor: 2.724

10.  The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism.

Authors:  Kun Zou; Caigang Liu; Zhuo Zhang; Lijuan Zou
Journal:  Clinics (Sao Paulo)       Date:  2015-08       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.